Table: Phoenixbio - 9-MTH group results

PhoenixBio

14/02/2024 06:30

Feb 14 (Reuters)- 
             Phoenixbio Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2023        Dec 31, 2022     Mar 31, 2024 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               1.33                1.66             1.82     
                   (-20.0 pct)         (+77.9 pct)      (-14.5 pct) 
  Operating          30 mln              464 mln           8 mln    
                   (-93.4 pct)                          (-98.3 pct) 
  Recurring          32 mln              446 mln          45 mln    
                   (-92.8 pct)                          (-91.0 pct) 
  Net                14 mln              393 mln          24 mln    
                   (-96.3 pct)                          (-95.1 pct) 
  EPS               3.89 yen           117.70 yen        6.62 yen   
  EPS Diluted                           78.09 yen                   
  Ann Div                                  NIL              NIL     
  -Q2 div              NIL                 NIL                      
  -Q4 div                                  NIL              NIL     
  
  NOTE - Phoenixbio Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T